AUD 0.03
(0.0%)
Year | Operating Income | Operating Income Growth |
---|---|---|
2024 | -7 Million AUD | -10.21% |
2023 | -6.35 Million AUD | 11.16% |
2022 | -7.14 Million AUD | 41.21% |
2021 | -12.16 Million AUD | -28.53% |
2020 | -9.46 Million AUD | 0.46% |
2019 | -9.5 Million AUD | -132.48% |
2018 | -4.08 Million AUD | -21.74% |
2017 | -3.35 Million AUD | 16.38% |
2016 | -4.01 Million AUD | 26.92% |
2015 | -5.49 Million AUD | 51.02% |
2014 | -11.22 Million AUD | -92.96% |
2013 | -5.81 Million AUD | -5.68% |
2012 | -5.5 Million AUD | 19.12% |
2011 | -6.8 Million AUD | -11.1% |
2010 | -6.12 Million AUD | 11.13% |
2009 | -6.89 Million AUD | 44.91% |
2008 | -12.5 Million AUD | -248.95% |
2007 | -3.58 Million AUD | -306.06% |
2006 | -882.8 Thousand AUD | -18.95% |
2005 | -742.18 Thousand AUD | 11.0% |
2004 | -833.9 Thousand AUD | 82.16% |
2003 | -4.67 Million AUD | 61.51% |
2002 | -12.14 Million AUD | -6395.17% |
2001 | -187 Thousand AUD | 96.8% |
2000 | -5.84 Million AUD | -225.41% |
1999 | -1.79 Million AUD | -151.51% |
1998 | -714.42 Thousand AUD | -141.01% |
1997 | 1.74 Million AUD | 0.0% |
Year | Operating Income | Operating Income Growth |
---|---|---|
2024 Q2 | -3.7 Million AUD | 0.0% |
2024 FY | -7.95 Million AUD | -25.2% |
2024 Q4 | -3.96 Million AUD | 0.0% |
2023 Q2 | -3.16 Million AUD | 0.0% |
2023 Q4 | -3.18 Million AUD | 0.0% |
2023 FY | -6.35 Million AUD | 11.16% |
2022 Q2 | -3.56 Million AUD | 0.0% |
2022 FY | -7.14 Million AUD | 41.21% |
2022 Q4 | -3.58 Million AUD | 0.0% |
2021 Q4 | -4.73 Million AUD | 0.0% |
2021 Q2 | -7.47 Million AUD | 0.0% |
2021 FY | -12.16 Million AUD | -28.53% |
2020 FY | -9.46 Million AUD | 0.46% |
2020 Q2 | -3.57 Million AUD | 0.0% |
2020 Q4 | -5.88 Million AUD | 0.0% |
2019 FY | -9.5 Million AUD | -132.48% |
2019 Q4 | -4.34 Million AUD | 0.0% |
2019 Q2 | -3.1 Million AUD | 0.0% |
2018 FY | -4.08 Million AUD | -21.74% |
2018 Q2 | -793.64 Thousand AUD | 0.0% |
2018 Q4 | -2.43 Million AUD | 0.0% |
2017 Q2 | -1.87 Million AUD | 0.0% |
2017 Q4 | -664.67 Thousand AUD | 0.0% |
2017 FY | -3.35 Million AUD | 16.38% |
2016 Q4 | -1.4 Million AUD | 0.0% |
2016 Q2 | -2.61 Million AUD | 0.0% |
2016 FY | -4.01 Million AUD | 26.92% |
2015 Q4 | -2.43 Million AUD | 0.0% |
2015 FY | -5.49 Million AUD | 51.02% |
2015 Q2 | -3.06 Million AUD | 0.0% |
2014 Q2 | -7.31 Million AUD | 0.0% |
2014 FY | -11.22 Million AUD | -92.96% |
2014 Q4 | -3.91 Million AUD | 0.0% |
2013 Q2 | -2.92 Million AUD | -112.7% |
2013 Q1 | -1.37 Million AUD | 0.0% |
2013 FY | -5.81 Million AUD | -5.68% |
2013 Q4 | -2.68 Million AUD | -84.7% |
2013 Q3 | -1.45 Million AUD | 50.32% |
2012 Q4 | - AUD | 100.0% |
2012 FY | -5.5 Million AUD | 19.12% |
2012 Q2 | -1.37 Million AUD | 19.12% |
2012 Q3 | -1.37 Million AUD | 0.0% |
2012 Q1 | -1.7 Million AUD | 0.0% |
2011 Q2 | -1.7 Million AUD | -11.1% |
2011 Q1 | -1.53 Million AUD | 0.0% |
2011 FY | -6.8 Million AUD | -11.1% |
2011 Q4 | - AUD | 100.0% |
2011 Q3 | -1.7 Million AUD | 0.0% |
2010 Q4 | - AUD | 100.0% |
2010 Q3 | -1.53 Million AUD | 0.0% |
2010 Q1 | -1.72 Million AUD | 0.0% |
2010 Q2 | -1.53 Million AUD | 11.13% |
2010 FY | -6.12 Million AUD | 11.13% |
2009 Q3 | -1.72 Million AUD | 0.0% |
2009 Q2 | -1.72 Million AUD | 44.91% |
2009 Q4 | - AUD | 100.0% |
2009 FY | -6.89 Million AUD | 44.91% |
2009 Q1 | -3.12 Million AUD | 0.0% |
2008 Q2 | -3.12 Million AUD | -248.95% |
2008 Q4 | - AUD | 100.0% |
2008 FY | -12.5 Million AUD | -248.95% |
2008 Q1 | -896.17 Thousand AUD | 0.0% |
2008 Q3 | -3.12 Million AUD | 0.0% |
2007 Q1 | -220.7 Thousand AUD | 0.0% |
2007 FY | -3.58 Million AUD | -306.06% |
2007 Q4 | - AUD | 100.0% |
2007 Q3 | -896.17 Thousand AUD | 0.0% |
2007 Q2 | -896.17 Thousand AUD | -306.06% |
2006 Q3 | -220.7 Thousand AUD | 0.0% |
2006 Q2 | -220.7 Thousand AUD | -18.95% |
2006 FY | -882.8 Thousand AUD | -18.95% |
2006 Q4 | - AUD | 100.0% |
2006 Q1 | -185.54 Thousand AUD | 0.0% |
2005 FY | -742.18 Thousand AUD | 11.0% |
2005 Q3 | -185.54 Thousand AUD | 0.0% |
2005 Q2 | -185.54 Thousand AUD | 11.0% |
2005 Q1 | -208.47 Thousand AUD | 0.0% |
2005 Q4 | - AUD | 100.0% |
2004 Q1 | -1.16 Million AUD | 0.0% |
2004 Q2 | -208.47 Thousand AUD | 82.16% |
2004 Q3 | -208.47 Thousand AUD | 0.0% |
2004 Q4 | - AUD | 100.0% |
2004 FY | -833.9 Thousand AUD | 82.16% |
2003 Q4 | - AUD | 100.0% |
2003 Q1 | -3.03 Million AUD | 0.0% |
2003 Q2 | -1.16 Million AUD | 61.51% |
2003 Q3 | -1.16 Million AUD | 0.0% |
2003 FY | -4.67 Million AUD | 61.51% |
2002 Q3 | -3.03 Million AUD | 0.0% |
2002 Q1 | -46.75 Thousand AUD | 0.0% |
2002 Q4 | - AUD | 100.0% |
2002 Q2 | -3.03 Million AUD | -6395.17% |
2002 FY | -12.14 Million AUD | -6395.17% |
2001 Q1 | -2.99 Million AUD | 0.0% |
2001 Q4 | - AUD | 100.0% |
2001 Q3 | -46.75 Thousand AUD | 0.0% |
2001 Q2 | -46.75 Thousand AUD | 98.44% |
2001 FY | -187 Thousand AUD | 96.8% |
2000 Q3 | -2.99 Million AUD | 0.0% |
2000 Q1 | -449.2 Thousand AUD | 0.0% |
2000 FY | -5.84 Million AUD | -225.41% |
2000 Q4 | -2.99 Million AUD | 0.0% |
2000 Q2 | -2.99 Million AUD | -565.68% |
1999 FY | -1.79 Million AUD | -151.51% |
1999 Q3 | -449.2 Thousand AUD | 0.0% |
1999 Q4 | -449.2 Thousand AUD | 0.0% |
1999 Q2 | -449.2 Thousand AUD | -151.51% |
1999 Q1 | -178.6 Thousand AUD | 0.0% |
1998 Q4 | -178.6 Thousand AUD | 0.0% |
1998 Q3 | -178.6 Thousand AUD | 0.0% |
1998 FY | -714.42 Thousand AUD | -141.01% |
1998 Q1 | 435.47 Thousand AUD | 0.0% |
1998 Q2 | -178.6 Thousand AUD | -141.01% |
1997 FY | 1.74 Million AUD | 0.0% |
1997 Q4 | 435.47 Thousand AUD | 0.0% |
1997 Q2 | 435.47 Thousand AUD | 0.0% |
1997 Q3 | 435.47 Thousand AUD | 0.0% |
Name | Operating Income | Operating Income Difference |
---|---|---|
4DMedical Limited | -27.96 Million AUD | 74.969% |
Adherium Limited | -11.98 Million AUD | 41.594% |
Aroa Biosurgery Limited | -9.78 Million AUD | 28.48% |
Atomo Diagnostics Limited | -4.36 Million AUD | -60.501% |
Anteris Technologies Ltd | -66.63 Million AUD | 89.494% |
Control Bionics Limited | -5.92 Million AUD | -18.062% |
CardieX Limited | -4.63 Million AUD | -51.071% |
Compumedics Limited | -269 Thousand AUD | -2502.305% |
Cochlear Limited | 521.5 Million AUD | 101.342% |
CleanSpace Holdings Limited | -4.81 Million AUD | -45.414% |
Cyclopharm Limited | -9.22 Million AUD | 24.114% |
EMVision Medical Devices Ltd | -1.61 Million AUD | -333.608% |
Nova Eye Medical Limited | -3.79 Million AUD | -84.361% |
HeraMED Limited | -6.42 Million AUD | -8.902% |
Imricor Medical Systems, Inc. | -17.57 Million AUD | 60.17% |
ImpediMed Limited | -19.03 Million AUD | 63.227% |
InhaleRx Limited | -1.38 Million AUD | -404.888% |
LBT Innovations Limited | -4.74 Million AUD | -47.684% |
Micro-X Limited | -13.02 Million AUD | 46.264% |
Neurotech International Limited | -5.58 Million AUD | -25.344% |
OncoSil Medical Limited | -11.98 Million AUD | 41.588% |
PolyNovo Limited | 1.16 Million AUD | 701.909% |
SomnoMed Limited | -3.84 Million AUD | -82.235% |
Universal Biosensors, Inc. | -16.68 Million AUD | 58.033% |
Uscom Limited | -2.4 Million AUD | -191.147% |
Visioneering Technologies, Inc. | -5.85 Million AUD | -19.577% |